Celldex Therapeutics buy Stifel Nicolaus
Start price
18.06.24
/
50%
€33.20
Target price
18.06.25
€54.03
Performance (%)
-45.18%
End price
19.06.25
€18.20
Summary
This prediction ended on 19.06.25 with a price of €18.20. The BUY prediction by Stifel_Nicolaus for Celldex Therapeutics performed very badly with a performance of -45.18%. Stifel_Nicolaus has a follow-up prediction for Celldex Therapeutics where he still thinks Celldex Therapeutics is a Buy. Stifel_Nicolaus has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Celldex Therapeutics | 14.315% | 14.315% | 99.648% |
| iShares Core DAX® | 2.554% | 0.562% | 14.142% |
| iShares Nasdaq 100 | 2.742% | -0.599% | 30.370% |
| iShares Nikkei 225® | 6.584% | 4.336% | 49.372% |
| iShares S&P 500 | 1.930% | -0.507% | 24.257% |
Comments by Stifel_Nicolaus for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics, Inc. (NASDAQ: CLDX) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $58.00 price target on the stock.
Ratings data for CLDX provided by MarketBeat
In the thread Trading Celldex Therapeutics
Die von Stifel_Nicolaus gewählte maximale Laufzeit wurde überschritten